|
79
|
274
|
2o3pA |
Crystal structure of pim1 with quercetin |
|
81
|
294
|
2owbA |
Structure of the catalytic domain of human polo-like kinase 1 |
|
71
|
348
|
2onlC |
Crystal structure of the p38a-mapkap kinase 2 heterodimer |
|
105
|
344
|
2ojiA |
Crystal structure of erk2 in complex with n-benzyl-4-(4-(3-chlorophenyl)-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide |
|
78
|
278
|
2oiqA |
Crystal structure of chicken c-src kinase domain in complex with the cancer drug imatinib. |
|
98
|
325
|
2oxdA |
Protein kinase ck2 in complex with tetrabromobenzoimidazole k17, k22 and k32 inhibitors |
|
111
|
344
|
2ojjA |
Crystal structure of erk2 in complex with (s)-n-(1-(3-chloro-4-fluorophenyl)-2-hydroxyethyl)-4-(4-(3-chlorophenyl)-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide |
|
91
|
296
|
2oicA |
Crystal structure of irak4 kinase domain complexed with staurosporine |
|
75
|
268
|
2ofvA |
Crystal structure of aminoquinazoline 1 bound to lck |
|
82
|
273
|
2objA |
Crystal structure of human pim-1 kinase in complex with inhibitor |
|
95
|
297
|
2oibA |
Crystal structure of irak4 kinase domain apo form |
|
79
|
350
|
2o5kA |
Crystal structure of gsk3beta in complex with a benzoimidazol inhibitor |
|
80
|
280
|
2oscA |
Synthesis, structural analysis, and sar studies of triazine derivatives as potent, selective tie-2 inhibitors |
|
99
|
355
|
2ok1A |
Crystal structure of jnk3 bound to n-benzyl-4-(4-(3-chlorophenyl)-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide |
|
104
|
339
|
2ojgA |
Crystal structure of erk2 in complex with n,n-dimethyl-4-(4-phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide |
|
86
|
317
|
2ogvA |
Crystal structure of the autoinhibited human c-fms kinase domain |
|
88
|
273
|
2ofuA |
X-ray crystal structure of 2-aminopyrimidine carbamate 43 bound to lck |
|
90
|
295
|
2o8yA |
Apo irak4 kinase domain |
|
95
|
305
|
2oh4A |
Crystal structure of vegfr2 with a benzimidazole-urea inhibitor |
|
74
|
263
|
2og8A |
Crystal structure of aminoquinazoline 36 bound to lck |
|
77
|
274
|
2o65A |
Crystal structure of pim1 with pentahydroxyflavone |
|
99
|
349
|
2onlA |
Crystal structure of the p38a-mapkap kinase 2 heterodimer |
|
84
|
295
|
2oidA |
Crystal structure of irak4 kinase domain complexed with amppnp |
|
85
|
275
|
2oi4X |
Crystal structure of human pim1 in complex with fluorinated ruthenium pyridocarbazole |
|
88
|
271
|
2of2A |
Crystal structure of furanopyrimidine 8 bound to lck |
|
81
|
274
|
2o64A |
Crystal structure of pim1 with quercetagetin |
|
105
|
355
|
2o2uA |
Crystal structure of human jnk3 complexed with n-(3-cyano-4,5,6,7-tetrahydro-1-benzothien-2-yl)-2-fluorobenzamide |
|
86
|
295
|
2nruA |
Crystal structure of irak-4 |
|
95
|
355
|
2o0uA |
Crystal structure of human jnk3 complexed with n-{3-cyano-6-[3-(1-piperidinyl)propanoyl]-4,5,6,7-tetrahydrothieno[2,3-c]pyridin-2-yl}-1-naphthalenecarboxamide |
|
108
|
348
|
2npqA |
A novel lipid binding site in the p38 alpha map kinase |
|
109
|
359
|
2lgcA |
Joint nmr and x-ray refinement reveals the structure of a novel dibenzo[a,d]cycloheptenone inhibitor/p38 map kinase complex in solution |
|
93
|
360
|
2kulA |
Solution structure of human vaccinia related kinase 1(vrk1) |
|
96
|
357
|
2no3A |
Novel 4-anilinopyrimidines as potent jnk1 inhibitors |
|
82
|
262
|
2np8A |
Structural basis for the inhibition of aurora a kinase by a novel class of high affinity disubstituted pyrimidine inhibitors |
|
67
|
360
|
2ktyA |
Solution structure of human vaccinia related kinase-1 |
|
88
|
295
|
2nryA |
Crystal structure of irak-4 |
|
82
|
288
|
2jfmA |
Crystal structure of human ste20-like kinase (unliganded form) |
|
102
|
363
|
2jd5A |
Sky1p bound to npl3p-derived substrate peptide |
|
82
|
272
|
2jkkA |
Focal adhesion kinase catalytic domain in complex with bis-anilino pyrimidine inhibitor |
|
80
|
305
|
2jbpA |
Protein kinase mk2 in complex with an inhibitor (crystal form-2, co- crystallization) |
|
92
|
337
|
2jdoA |
Structure of pkb-beta (akt2) complexed with isoquinoline-5-sulfonic acid (2-(2-(4-chlorobenzyloxy) ethylamino)ethyl)amide |
|
74
|
320
|
2jiuA |
Crystal structure of egfr kinase domain t790m mutation in complex with aee788 |
|
79
|
273
|
2jkqA |
Focal adhesion kinase catalytic domain in complex with bis-anilino pyrimidine inhibitor |
|
105
|
336
|
2jdtA |
Structure of pka-pkb chimera complexed with isoquinoline-5-sulfonic acid (2-(2-(4-chlorobenzyloxy) ethylamino)ethyl)amide |
|
83
|
272
|
2jkoA |
Focal adhesion kinase catalytic domain in complex with bis-anilino pyrimidine inhibitor |
|
112
|
332
|
2jiiA |
Structure of vaccinia related kinase 3 |
|
97
|
326
|
2jedA |
The crystal structure of the kinase domain of the protein kinase c theta in complex with nvp-xaa228 at 2.32a resolution. |
|
92
|
337
|
2jdrA |
Structure of pkb-beta (akt2) complexed with the inhibitor a-443654 |
|
102
|
351
|
2jldA |
Extremely tight binding of ruthenium complex to glycogen synthase kinase 3 |
|
73
|
261
|
2j50A |
Structure of aurora-2 in complex with pha-739358 |
